98%
921
2 minutes
20
C-type lectins (CTLs) have a diverse range of functions including cell-cell adhesion, immune response to pathogens and apoptosis. Asialoglycoprotein receptor (ASGPR), also known as hepatic lectin, a member of CTLs, was the first animal lectin identified, yet information regarding it remains rather limited in teleost. In this study, we identified a putative protein in zebrafish, named as the zebrafish hepatic lectin (Zhl). The zhl encoded a typical Ca-dependent carbohydrate-binding protein, and was mainly expressed in the liver in a tissue specific fashion. Challenge with LPS and LTA resulted in significant up-regulation of zhl expression, suggesting involvement in immune response. Actually, recombinant C-type lectin domain (rCTLD) of Zhl was found to be capable of agglutinating and binding to both Gram-negative and Gram-positive bacteria and enhancing the phagocytosis of the bacteria by macrophages. Moreover, rCTLD specifically bound to insoluble lipopolysaccharide (LPS), lipoteichoic acid (LTA) and peptidoglycan (PGN), which were inhibited by galactose. Interestingly, Zhl was located in the membrane, and its overexpression could inhibit the production of pre-inflammatory cytokines. Taken together, these results indicate that Zhl has immune activity capable of defending invading pathogens, enriching our understanding of the function of ASGPR/hepatic lectin.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.fsi.2018.08.012 | DOI Listing |
Int J Biol Macromol
September 2025
College of pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China; Shandong Key Laboratory of Digital Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China. Electronic address:
Hepatocellular carcinoma (HCC) poses a serious threat to human life and health. Nowadays, liver-targeting drug delivery systems have been proven as a promising strategy in treating HCC. Angelica sinensis polysaccharide (ASP), a plant polysaccharide with good biocompatibility, has excellent aqueous solubility and intrinsic liver-targeted capability.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
Hengyang Medical School, The Affiliated Changsha Central Hospital, Changsha Tuberculosis Research Institute, University of South China, Changsha, China.
Sialic acid is a common terminal monosaccharide residue on glycan chains, and desialylation of glycoproteins is considered an important biological signal. In the liver and other cell types, asialoglycoprotein receptor 1 (ASGR1) specifically recognizes and binds to exposed galactose or N-acetylgalactosamine (Gal/GalNAc) residues on desialylated glycoproteins, and activates downstream signaling pathways through receptor-mediated endocytosis (RME), thereby playing important roles in various physiological and pathological processes such as immune regulation, viral infection, hepatocellular carcinoma progression, and lipid metabolism. In addition, ASGR1 is regarded as a key target for liver-specific drug delivery.
View Article and Find Full Text PDFSLAS Discov
August 2025
Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Hepatocyte-specific Asialoglycoprotein receptor (ASGPR) and its native ligand N-acetylgalactosamine (GalNAc) have been actively exploited for targeted delivery of therapeutic and diagnostic agents to the liver. Identification of new potent ligands of ASGPR is of high interest to advance this field and expand to new applications in drug discovery. However, success of novel potent ASGPR ligand discovery has been limited due to the lack of robust high-throughput assays amenable to High-Throughput Screening (HTS).
View Article and Find Full Text PDFBiol Trace Elem Res
August 2025
Department of Nephrology, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, Jilin Province, 130021, China.
The association between serum zinc levels and diabetic kidney disease (DKD) has been a focus of considerable scientific interest. Lower serum zinc has been observed to be involved in the progression of DKD, and zinc supplementation can improve the kidney damage of DKD. However, the causal link and the underlying mechanisms driving this association remain poorly understood.
View Article and Find Full Text PDFDrug Metab Dispos
August 2025
Research Center of Clinical Pharmacology, China Pharmaceutical University, Nanjing, Jiangsu, China.
DTX-007 is a double-stranded small-interfering RNA that decreases the expression of the proprotein convertase subtilisin/kexin type 9 protein through downregulation of its mRNA by conjugating with 3 N-acetylgalactosamine moieties to improve its hepatic distribution when administered via subcutaneous injection for the treatment of hypercholesterolemia. The nonclinical pharmacokinetics and the absorption, distribution, metabolism, and excretion characteristics of DTX-007 were evaluated in both in vivo and in vitro systems. Plasma protein binding exhibited concentration dependence across all examined species, approximating 99% at clinically relevant concentrations in humans.
View Article and Find Full Text PDF